Comparison of 585 and 595 nm laser-induced vascular response of normal in vivo human skin.

Comparison of 585 and 595 nm laser-induced vascular response of normal in vivo human skin.
复制标题

585 和 595 nm 激光诱导正常体内人体皮肤血管反应的比较。

DOI:
10.1002/lsm.20147
复制
发表时间:
2005
影响因子:
2.4
通讯作者:
Anvari,Bahman
Anvari,Bahman
中科院分区:
医学3区
文献类型:
--
作者:
Pikkula,BrianM;Chang,DavidW;Nelson,JStuart;Anvari,Bahman

文献摘要

参考文献

相似文献

Background and ObjectivesTwo wavelengths, 585 and 595 nm, are currently common options for treating vascular malformations such as port‐wine stains (PWS). Controversy exists as to which wavelength induces greater photothermal damage to the blood vessels and subsequent resolution of the malformations.Study Design/Materials and MethodsWe irradiated normal, human skin in vivo at 585 and 595 nm wavelengths using fluences of 10–30 J/cm2with a 1.5 millisecond laser pulse. The level of purpura, total vascular damage, maximum coagulation depth (MCD), and perivascular damage were quantified by gross observation and histological analysis.ResultsResults demonstrated that 585 nm light caused greater purpura, vascular damage, maximum coagulation depth, and perivascular damage than 595 nm. Purpura showed a positive correlation with total vascular damage to a certain extent beyond which the total vascular damage did not change. For equivalent purpura, 585 and 595 nm produced no statistically significant difference in vascular damage. The difference in the laser‐induced vascular damage between 585 and 595 nm, although statistically significant, was no more than 50%.ConclusionsThe bathochromic (red) shift and formation of met‐hemoglobin, which reduces the 585 nm light absorption and increases that of 595 nm compared to native oxy‐hemoglobin, play a considerable role in creating more parity in vascular damage between the two wavelengths than would be expected based on their respective “native” absorption coefficients alone. Lasers Surg. Med. 36:117–123, 2005. © 2005 Wiley‐Liss, Inc.
慢性肾衰竭中的三环类抗抑郁药和代谢物水平
DOI: --
发表时间: 1985
期刊: Clinical pharmacology and therapy
影响因子: --
作者:
J. Lieberman;T. Cooper;R. Suckow;Herbert Steinberg;M. Borenstein;R. Brenner;John M. Kane
通讯作者: John M. Kane
去甲替林的 E-和 Z-10-羟基化:与多晶型异喹啉羟基化的关系
DOI: --
发表时间: 1981
期刊: Clinical pharmacology and therapy
影响因子: --
作者:
B. Mellström;L. Bertilsson;J. Säwe;Hans;F. Sjöqvist
通讯作者: F. Sjöqvist
史密斯克莱恩和法国回复
DOI: --
发表时间: 1985
期刊:
影响因子: --
作者:
M. L. Young
通讯作者: M. L. Young
老年抑郁症患者的心电图变化以及地昔帕明和 2-羟基-地昔帕明的治疗浓度
DOI: --
发表时间: 1986
影响因子: 10.5
作者:
S. Kutcher;K. Reid;J. Dubbin;K. Shulman
通讯作者: K. Shulman
老年抑郁症患者羟基地昔帕明浓度的变化
DOI: --
发表时间: 1982
期刊: Clinical pharmacology and therapy
影响因子: --
作者:
I. Kitanaka;R. Ross;N. Cutler;A. Zavadil;W. Potter
通讯作者: W. Potter